Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11400311 | 1.00 | APP (0.48) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL28736764 | 1.00 | APP (0.48) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL15348640 | 1.00 | APP (0.48) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL1404244 | 1.00 | APP (0.48) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL14963013 | 1.00 | APP (0.48) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL8378705 | 1.00 | APP (0.48) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL11408009 | 1.00 | APP (0.48) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL5187382 | 0.97 | APP (0.46) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL7105359 | 0.97 | APP (0.46) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL7103482 | 0.97 | APP (0.46) | APPPTGS1PDE4ALMNASLC6A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119909543-A | Negatively charged composite nanofiltration membrane and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-114361469-B | Fuel cell catalytic layer and fuel cell | 北京理工大学 | 2024-04-12 | — | — | CN | claimed |
| CN-114044894-B | Tertiary amine group-containing aryl ether-based polymer, preparation method thereof and quaternary ammonium salt modified polyarylether-based ultrafiltration membrane | 吉林大学 | 2022-08-12 | — | — | CN | claimed |
| CN-114361469-A | Fuel cell catalyst layer and fuel cell | 北京理工大学 | 2022-04-15 | — | — | CN | claimed |
| CN-114044894-A | Tertiary amine group-containing aryl ether-based polymer, preparation method thereof and quaternary ammonium salt modified polyarylether-based ultrafiltration membrane | 吉林大学 | 2022-02-15 | — | — | CN | claimed |
| CN-119909543-A | Negatively charged composite nanofiltration membrane and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-05-02 | — | — | CN | disclosed |
| CN-114361469-B | Fuel cell catalytic layer and fuel cell | 北京理工大学 | 2024-04-12 | — | — | CN | disclosed |
| CN-114044894-B | Tertiary amine group-containing aryl ether-based polymer, preparation method thereof and quaternary ammonium salt modified polyarylether-based ultrafiltration membrane | 吉林大学 | 2022-08-12 | — | — | CN | disclosed |
| CN-114361469-A | Fuel cell catalyst layer and fuel cell | 北京理工大学 | 2022-04-15 | — | — | CN | disclosed |
| CN-114044894-A | Tertiary amine group-containing aryl ether-based polymer, preparation method thereof and quaternary ammonium salt modified polyarylether-based ultrafiltration membrane | 吉林大学 | 2022-02-15 | — | — | CN | disclosed |
| EP-3091019-B1 | PURINE DERIVATIVES USEFUL AS HSP90 INHIBITORS | SLOAN KETTERING INST CANCER RES (US) | 2019-04-03 | — | — | EP | disclosed |
| US-20160310497-A1 | PURINE DERIVATIVES USEFUL AS HSP90 INHIBITORS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 2016-10-27 | — | — | US | disclosed |
| US-20120208806-A1 | Hsp90 Inhibitors | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2012-08-16 | — | — | US | disclosed |
| WO-2011044394-A1 | PURINE DERIVATIVES USEFUL AS HSP90 INHIBITORS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2011-04-14 | — | — | WO | disclosed |
| US-7803826-B2 | Imidazolidine derivatives | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2010-09-28 | — | — | US | disclosed |
| US-20070249697-A1 | Novel Imidazolidine Derivatives | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2007-10-25 | — | — | US | disclosed |
| US-20070249697-A1 | Novel Imidazolidine Derivatives | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2007-10-25 | — | — | US | disclosed |
| EP-1775289-A1 | NOVEL IMIDAZOLIDINE DERIVATIVES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2007-04-18 | — | — | EP | disclosed |
| US-5986042-A | Cross-linked polymer | MITSUI CHEMICALS, INC. (JP) | 1999-11-16 | — | — | US | disclosed |
| EP-0856539-A1 | Cross-linked polymer | Mitsui Chemicals, Inc. (JP) | 1998-08-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120208806-A1 | Hsp90 Inhibitors | HSP90B1, HSP90AB1, HSP90AB2P | APP 4196/4885PTGS1 1124/4885PDE4A 3029/4885 |
| US-20160310497-A1 | PURINE DERIVATIVES USEFUL AS HSP90 INHIBITORS | XDH, HSP90B1, HSP90AA1 | APP 3530/4885PTGS1 1266/4885PDE4A 636/4885 |
| US-20070249697-A1 | Novel Imidazolidine Derivatives | CYP3A4, CYP4B1, OPRD1 | APP 4172/4885PTGS1 2208/4885PDE4A 1268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.